Search

everythinglearnresearchcommunity

for

Search:↓

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Tofacitinib helped regrow hair in most patients with severe hair loss.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Polycaprolactone and barium titanate composites show promise for use in biomedical applications.

ATP helps prevent skin damage from vandetanib by reducing stress.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Tofacitinib may effectively treat folliculitis decalvans.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

Acid inside cells speeds up aging and turns on aging signs in mice.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.